| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/18/2004 | EP1389218A2 Cleavage and polyadenylation complex of precursor mrna |
| 02/18/2004 | EP1389217A2 Antimicrobial polypeptide |
| 02/18/2004 | EP1389186A2 Recombinant simian gpr3 receptor |
| 02/18/2004 | EP1389132A2 Peg-conjugates of hgt-nk4 |
| 02/18/2004 | EP1389130A2 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 02/18/2004 | EP1389123A1 A non-lethal method for extracting crude hemocyanin from gastropod molluscs |
| 02/18/2004 | EP1389060A1 Imaging of a region in a scattering medium |
| 02/18/2004 | EP1389042A1 Sprr1a and axonal regeneration |
| 02/18/2004 | EP1123314B1 Use of a cytokine-producing lactococcus strain to treat colitis |
| 02/18/2004 | EP1089755B1 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
| 02/18/2004 | EP1028744B1 Neuronal uses of bmp-11 |
| 02/18/2004 | EP0948337B1 Treatment of hemoglobin containing erythrocytes with nitric oxide |
| 02/18/2004 | EP0817851B1 Dna encoding human papilloma virus type 18 |
| 02/18/2004 | EP0791064B1 Method for enhancing the immunogenicity of an immunogenic compound or hapten, and use thereof for preparing vaccines |
| 02/18/2004 | EP0734264B1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 02/18/2004 | EP0731838B1 Binding structures directed against the ca55.1 antigen |
| 02/18/2004 | EP0728012B1 NOVEL GnRH ANALOGUES WITH ANTITUMOUR EFFECTS AND PHARMACEUTICAL COMPOSITIONS THEREOF |
| 02/18/2004 | EP0720482B1 Prosaposin and cytokine-derived peptides as therapeutic agents |
| 02/18/2004 | CN1476483A Modified vaccinia ankara virus variant |
| 02/18/2004 | CN1476482A Protein translocation into plant cells |
| 02/18/2004 | CN1476480A Isolated peptides which bind to HLA-C molecules and uses thereof |
| 02/18/2004 | CN1476479A Human protooncogene and protein encoded therein |
| 02/18/2004 | CN1476478A Human cervical cancer 2 protooncogene and protein encoded therein |
| 02/18/2004 | CN1476477A Promoter expressing foreign gene in root and shoot apex |
| 02/18/2004 | CN1476476A Ligand/receptor specificity exchangers that redirect antibodies to receptors on pathogen |
| 02/18/2004 | CN1475577A Recombination human bone shaping protein-7 mature peptide |
| 02/18/2004 | CN1475571A Expression of recombination SARS virus gene in pleiomorphic Hansen yeast and its use |
| 02/18/2004 | CN1475570A Cutin forming cell growth factor-2 |
| 02/18/2004 | CN1475533A Insoluble silk fibroin film and preparation of silk fibroin pipe |
| 02/18/2004 | CN1475506A Fortified fusion protein FV-LDP-AE possessing angiopoiesis inhibiting and antitumour actions |
| 02/18/2004 | CN1475505A Human composite type alpha interferon protein N terminal tag structure |
| 02/18/2004 | CN1475504A Process for producing soy-bean whey separator |
| 02/18/2004 | CN1475503A New type human bone marrow substrate cell source growth inhibiting factor, its coded sequence and use |
| 02/18/2004 | CN1475502A New withered induced protein, its coded sequence and use |
| 02/18/2004 | CN1475501A New type human bone marrow substrate cell source 1 type phosphoric acid enzyme inhibition factor, its coded sequence and use |
| 02/18/2004 | CN1475500A New type human marrow differentiation tagged object its coded sequence and use |
| 02/18/2004 | CN1475499A New type human cell signal related protein, its code sequence and use |
| 02/18/2004 | CN1475498A Preparation of antigen sensitized human dendron shaped cell and its use |
| 02/18/2004 | CN1475497A Transcription factor for regulating and controlling dry land cotton anti contrary property and its coded gene and application |
| 02/18/2004 | CN1475496A Soybean ethylene response protein transcription factor and its coded gene and application |
| 02/18/2004 | CN1475495A Ethylene response conjugated protein transcription factor of ice plant and its coded gene and application |
| 02/18/2004 | CN1138859C Infection clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| 02/18/2004 | CN1138786C Antibody for identifying osteoclast forming inhibitor binding protein, and preparing process and use |
| 02/18/2004 | CN1138785C Application of growth factor neuregulin and its analogs |
| 02/18/2004 | CN1138564C Influenza vaccine |
| 02/18/2004 | CN1138505C Anti-angiogenic compositions and method of use |
| 02/17/2004 | WO2004076645A3 Compositions and methods for cytomegalovirus treatment |
| 02/17/2004 | WO2004006898A3 Use of compounds capable of inhibiting the proteolytic processing of semaphorins for prevention, treatment, diagnosis and prognosis of an invasive disease |
| 02/17/2004 | US6693228 Alteration of flowering time in plants |
| 02/17/2004 | US6693226 First model for tau pathology in alzheimer's disease |
| 02/17/2004 | US6693186 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof |
| 02/17/2004 | US6693184 DNA molecules encoding splice variants of the human melanocortin 1 receptor protein |
| 02/17/2004 | US6693182 Mammalian galanin receptors |
| 02/17/2004 | US6693181 Protein secretion |
| 02/17/2004 | US6693174 Nucleotide sequences coding fungicide for use in the prevention of fungal infections |
| 02/17/2004 | US6693173 Removing multivalent ions from protein; obtain solution containing protein, adjust hydrogen ion concentration, diafilter solution, recover retentate |
| 02/17/2004 | US6693172 Isolated polypeptide amino acid sequence 14; measuring cellular ion channel transmission; identification of ligand gated agonists and modulators |
| 02/17/2004 | US6693171 ACPL polypeptides |
| 02/17/2004 | US6693170 ARIP4 gene and protein |
| 02/17/2004 | US6693169 Laminin 5, 13 and 14 and uses thereof |
| 02/17/2004 | US6693165 Cyclic peptides as potent and selective melanocortin-4 receptor antagonists |
| 02/17/2004 | US6693087 Nucleic acid molecules encoding POMP91A protein of Chlamydia |
| 02/17/2004 | US6693081 Bone stimulating factor |
| 02/17/2004 | US6693079 Insulin-like growth factor agonist molecules |
| 02/17/2004 | US6693078 Insulin-like growth factor agonist molecules |
| 02/17/2004 | US6693077 Keratinocyte growth factor-2 |
| 02/17/2004 | US6693076 Treating disorders by application of insulin-like growth factors and analogs |
| 02/17/2004 | US6693075 Factor viia polypeptide comprising modified carboxyglutamic acid domain; enhancing membrane binding affinity and activity |
| 02/17/2004 | US6692966 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 02/17/2004 | US6692962 Construct for knocking out eif2 alpha gene |
| 02/17/2004 | US6692956 Recombinant adenoviral vectors |
| 02/17/2004 | US6692955 HIV vaccine |
| 02/17/2004 | US6692951 Protein particle for use as genetic engineering tool in expression of heterologous proteins in bacillus |
| 02/17/2004 | US6692943 Persephin and related growth factors |
| 02/17/2004 | US6692941 Bovine growth hormone |
| 02/17/2004 | US6692940 Utilizing nucleotides 1 to 3060 of sequence number 3 or subsequence thereof |
| 02/17/2004 | US6692939 Nucleotide sequences encoding mammalian calcium activated chloride channel-adhesion molecules |
| 02/17/2004 | US6692938 Peptide for use in the treatment of inflammation, arthritis, glomerulonephritis, asthma, psoriasis, viral infections, cancer, atherosclerosis, leukemia and autoimmune diseases |
| 02/17/2004 | US6692937 Nucleotide sequences coding membrane protein for use in the treatment of cancer, infection and heart defects |
| 02/17/2004 | US6692936 Novel polypeptide belonging to the class of proteins known as g-protein coupled receptors |
| 02/17/2004 | US6692935 Fusion of peptide or protein association domains designed to assemble in a complementary fashion, thereby providing multifunctional (poly)peptides |
| 02/17/2004 | US6692934 For targeting drugs to specific organs and for modulating the concentration of endogenous substrates |
| 02/17/2004 | US6692931 Recombinant glycoproteins, method for the production thereof, medicaments containing said glycoproteins and use thereof |
| 02/17/2004 | US6692929 Polypeptide; for use in detection of cell cycle modulators |
| 02/17/2004 | US6692926 Recombinant human SM-11044-binding receptor proteins exhibiting ligand-binding activities, and their use |
| 02/17/2004 | US6692925 Determining if a substance inhibits tgf- beta / alk1 induced smad1 phosphorylation |
| 02/17/2004 | US6692924 Methods of using cytokine receptor zalpha11 to detect its ligands |
| 02/17/2004 | US6692923 Tapasin-like protein |
| 02/17/2004 | US6692922 Method for identifying agents which modulate chemokine “MEC”-induced functions of CCR3 |
| 02/17/2004 | US6692920 Antibody which specifically binds to a polypeptide comprising a naturally occurring ammo acid sequence of a novel expressed chemokine (adec) from inflamed adenoid tissue |
| 02/17/2004 | US6692919 Activated forms of notch and methods based thereon |
| 02/17/2004 | US6692908 Prevention and treatment of HCV infection employing antibodies that inhibit the interaction of HCV virions with their receptor |
| 02/17/2004 | US6692907 Conserved motif of hepatitis C virus E2/NS1 region |
| 02/17/2004 | US6692753 Potentiation of the immune response |
| 02/17/2004 | US6692751 Methods and systems for producing recombinant viral antigens |
| 02/17/2004 | US6692749 Immunogenic composition comprising epstein-barr virus gp350 protein containing deletion of both transmembrane region and c-terminus, substantially free from gp220 protein |
| 02/17/2004 | US6692748 Adipocyte complement related protein zacrp3x2 and nucleic acids encoding zacrp3x2 |
| 02/17/2004 | US6692747 Peptide for use in the treatment of infections, viral and cancer diseases |
| 02/17/2004 | US6692746 Tumor killing effects of enterotoxins, superantigens, and related compounds |
| 02/17/2004 | US6692745 Retards binding of glycoprotein to cell surface; viricides |